Overactive%20bladder News

News

$Voiding school effective in kids with refractory OAB$

Voiding school effective in kids with refractory OAB

20200625180000

Inpatient bladder rehabilitation programmes, also called voiding school, leads to long-term improvements in children with refractory overactive bladder (OAB), a new study has found.

$Ospemifene effective against vulvovaginal atrophy in women with refractory OAB symptoms$

Ospemifene effective against vulvovaginal atrophy in women with refractory OAB symptoms

20200527060000

Ospemifene appears to produce significant improvements in bladder wall thickness and vaginal dryness, as well as reductions in the number of episodes of nocturia and urgency, among others, in women with vulvovaginal atrophy (VVA) and overactive bladder (OAB) symptoms refractory to β3-agonists or antimuscarinic drugs, a study has shown.

Elevated oestradiol levels protective against OAB during ovulation induction

20200410140000

A sharp increase in oestrogen levels confers a protective effect on overactive bladder (OAB) symptoms in women undergoing ovulation induction, a study has found.

Unhealthy voiding habits linked to overactive bladder in women

Jairia Dela Cruz, 20191015090000

Toileting behaviours such as convenience and delayed voiding, straining to void, and position preference are strongly associated with overactive bladder (OAB) symptoms in women, according to a study.

Mirabegron a promising treatment option for OAB symptoms in men

Jairia Dela Cruz, 20190318100000

Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.

$Selective bladder denervation shows potential for treating refractory OAB in women$

Selective bladder denervation shows potential for treating refractory OAB in women

20181012060000

Selective bladder denervation provides a minimally invasive treatment option for female patients with refractory overactive bladder (OAB), with data from two prospective feasibility studies showing that the intervention improves symptoms over 6 months of follow-up.

Mirabegron plus solifenacin shows promise in overactive bladder treatment

Jairia Dela Cruz, 20180913100000

A 12-month treatment course with the combination of mirabegron plus solifenacin is safe and effective in patients with overactive bladder (OAB), reducing the number of incontinence episodes and micturition without unexpected toxicities, according to the results of the phase III SYNERGY II study.

Sleep disturbance, fatigue in OAB linked to worse UI/OAB symptoms

20170902140000

There appears to be a substantial percentage of overactive bladder (OAB) patients who have sleep disturbance and fatigue, which are in turn associated with more severe urinary incontinence (UI)/OAB symptoms, worse health-related quality of life and poorer psychosocial health, a study has found.

GI bleeding less frequent with ticagrelor, prasugrel vs clopidogrel

Jairia Dela Cruz, Yesterday

In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.